Pros and cons of oclacitinib therapy.
暂无分享,去创建一个
[1] R. Mueller,et al. Sebaceous adenitis and mural folliculitis in a cat responsive to topical fatty acid supplementation. , 2016, Veterinary dermatology.
[2] M. Stegemann,et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. , 2015, Veterinary dermatology.
[3] E. Lee,et al. Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme , 2015, Annals of the rheumatic diseases.
[4] M. Stegemann,et al. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs , 2014, Veterinary dermatology.
[5] P. Kubler. Experimental and Clinical Pharmacology:Janus kinase inhibitors: Mechanisms of action , 2014 .
[6] Bingxuan Wang,et al. Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes , 2014, Current diabetes reviews.